Thermo Fisher completes $76M cell culture manufacturing site near Buffalo, NY
Thermo Fisher has completed the expansion of one of its manufacturing facilities in New York, taking another step forward in its broader investment plan for sites in the US and globally.
The $76 million expansion of its dry powder media manufacturing facility in Grand Island, New York, just north of Buffalo, will allow more capacity to support Thermo Fisher’s global supply and extend its capabilities for materials used in vaccines and biologic therapy development and manufacturing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.